Fidelity Investments slashes Juul Labs' valuation in Q2

Aug.02.2022
Fidelity Investments slashes Juul Labs' valuation in Q2
US investment group Fidelity significantly reduced Juul Labs Inc.'s valuation due to US vaping crackdown.

Fidelity Investments has significantly lowered the valuation of Juul Labs Inc. in the second quarter due to concerns over the U.S. crackdown on e-cigarettes.


According to data analysis collected by Bloomberg, asset management companies reported that their funds have reduced Juul's valuation by approximately 88%. The data shows that as of June 30th, Fidelity Funds lowered Juul's per share price from $41.01 on March 31st to $4.86, while during the same period, a capital group fund reduced the closely held company's stock price from $52.40 to $6.46.


These cuts have resulted in a series of write-downs for investors as the company undergoes FDA review. Altria Group Inc., the maker of Marlboro cigarettes, spent $12.8 billion in 2018 to acquire a 35% stake in Juul, but as of June 30th, their investment was only worth $450 million. According to PitchBook data, Tiger Global Management and Darsana Capital Partners have also invested in Juul, as has Dan Sundheim's D1 Capital Partners.


Representatives from Fidelity Investment Group declined to comment.


Statement:


This article is compiled based on third-party information and is intended for industry-related communication and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is intended only for industry exchange and research.


Due to limitations in our ability to accurately translate, the translated text may differ in expression from the original article. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government's positioning and stance on any domestic, cross-border including Hong Kong, Macau and Taiwan, or international issues.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to have the content removed.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Xinan Liu, Associate Researcher at the Brain Science Institute of CAS Shenzhen Institute of Advanced Technology, Speaks at 2Firsts Global NGP Rethink Forum
Xinan Liu, Associate Researcher at the Brain Science Institute of CAS Shenzhen Institute of Advanced Technology, Speaks at 2Firsts Global NGP Rethink Forum
Xinan Liu, Associate Researcher at the Brain Science Institute of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, delivered a keynote speech at the 2Firsts Global NGP Forum titled "The Global Opportunities and Challenges of The Novel Tobacco Industry from a Scientific Perspective".
Jul.30 by 2FIRSTS.ai
Denssi's Global Strategy: Swedish Nicotine Pouch Brand Focuses on Flavor Innovation, Brand Storytelling in Africa and Middle East
Denssi's Global Strategy: Swedish Nicotine Pouch Brand Focuses on Flavor Innovation, Brand Storytelling in Africa and Middle East
Denssi COO Callum Cherry highlights that the brand stands out globally with “great flavors” and a unique story. Using differentiated strategies and sports sponsorships, Denssi builds a youthful, passionate image, focusing on emerging markets in Africa and the Middle East.
Jun.19 by 2FIRSTS.ai
Imperial Tobacco Canada Survey: One Year Into Quebec’s Flavored Vape Ban, 76% of Users Still Buying Illicit Products
Imperial Tobacco Canada Survey: One Year Into Quebec’s Flavored Vape Ban, 76% of Users Still Buying Illicit Products
A survey commissioned by Imperial Tobacco Canada shows that sales of illicit flavored vaping products have risen following Quebec’s ban. Some 76% of adult vapers admitted to purchasing illegal products, up 8% from 2024. The share of sales through specialty stores climbed from 40% to 52%, highlighting worsening black market activity. Imperial Tobacco is urging stronger enforcement and a shift in regulatory strategy.
Jul.11 by 2FIRSTS.ai
Australias Pharmacies Sell Less Than 170 E - Cigarettes Daily, Over 7M Illegal E - Cigarettes Seized in 2024
Australias Pharmacies Sell Less Than 170 E - Cigarettes Daily, Over 7M Illegal E - Cigarettes Seized in 2024
After Australia's strict e-cigarette ban, legal sales are under 170 daily, but over 7 million illegal e-cigarettes were seized in 2024. The ban spurred black market growth. 18% of 18 - to 24 - year - olds still use e-cigarettes.Experts call for better law enforcement and supply system.
Jul.02 by 2FIRSTS.ai
Word Vape Show Insights| Divergent Brand-Overseas Routes: UK Brands Target the Middle East, Southeast Asian Brands Land in Africa, and US Hits Struggling for Exports?
Word Vape Show Insights| Divergent Brand-Overseas Routes: UK Brands Target the Middle East, Southeast Asian Brands Land in Africa, and US Hits Struggling for Exports?
At the 2025 Dubai World Vape Show, 2Firsts observed a clear trend: global vape brands are speeding up their overseas expansion, but their routes are parting.
Jun.20 by 2FIRSTS.ai
Photo Collection of New Products | Innokin, Aspire, ALD and Others Launch New - style Hookah Devices
Photo Collection of New Products | Innokin, Aspire, ALD and Others Launch New - style Hookah Devices
At the exhibition site, many brands showcased a variety of new-style hookah products in different forms.
Jun.23